Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

Clinical trial NCT07057791 · RECRUITING

Trial details

NCT number: NCT07057791
Sponsor: PrECOG, LLC.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Extensive Stage Lung Small Cell Cancer

Start date: 2026-03-30
Primary completion: 2027-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.